Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis-Reference-Cited by-同舟云学术

Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis

Published:2016-07 Issue:7 Volume:60 Page:4398-4400
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Aguilar-Company Juan¹^ORCID,Los-Arcos Ibai¹^ORCID,Pigrau Carles¹²,Rodríguez-Pardo Dolors¹²,Larrosa María Nieves³²,Rodríguez-Garrido Virginia³²,Sihuay-Diburga Denisse⁴,Almirante Benito¹²

Affiliation:

1. Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

2. Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III, Madrid, Spain

3. Microbiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

4. Gastroenterology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

Abstract

ABSTRACT We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00447-16

Reference16 articles.

1. Campylobacter jejuni Infections: Update on Emerging Issues and Trends

2. Bacteremia Due to Campylobacter Species: Clinical Findings and Antimicrobial Susceptibility Patterns

3. Macrolide resistance in Campylobacter jejuni and Campylobacter coli

4. Antimicrobial Susceptibility of Campylobacter jejuni and Campylobacter coli Isolates Obtained in Montreal, Quebec, Canada, from 2002 to 2013

5. Hypogammaglobulinemia and Recurrent Campylobacter jejuni Infection

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible Role of Cytomegalovirus in Gastric Cancer Development and Recurrent Macrolide-Resistant Campylobacter jejuni Infection in Common Variable Immunodeficiency: A Case Report and Literature Discussion;Microorganisms;2024-05-27

2. Cellulitis with bacteremia due to multidrug-resistant Campylobacter jejuni in a case of agammaglobulinemia and bronchiectasis;IDCases;2024

3. Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient;Antimicrobial Agents and Chemotherapy;2023-11-15

4. Chronic or recurrent Campylobacter enteritis in primary immunodeficiency: A UK national case-series and review of the literature;The Journal of Allergy and Clinical Immunology: In Practice;2023-09

5. Clinical and microbiological findings of recurrent Campylobacter spp. gastroenteritis in a tertiary care hospital;Enfermedades infecciosas y microbiologia clinica (English ed.);2023-02